AMBU B Ambu A/S Class B

Ambu A/S: Capital increase in connection with exercise of warrants issued

Ambu A/S: Capital increase in connection with exercise of warrants issued

In December 2013, Ambu A/S issued 2,000,000 warrants, in December 2014 2,000,000 warrants and in December 2015 770,000 warrants, each warrant entitling the holder to subscribe for one Class B share with a nominal value of DKK 0.50. 52 individuals participate in the 2013 scheme, 22 individuals participate in the 2014-scheme and 46 individuals participate in the 2015 scheme. In all cases, the vesting period is three years, and all schemes can therefore be exercised in the trading window that opened on 1 May 2019 in connection with Ambu’s interim financial report for Q2 2018/19.





Attachment

EN
09/05/2019

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Ambu A/S Class B

ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Morten Larsen
ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Morten Larsen

Ambu AS: 1 director

A director at Ambu AS bought 10,500 shares at 82.900DKK and the significance rating of the trade was 50/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showi...

ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Morten Larsen
ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Morten Larsen

ResearchPool Subscriptions

Get the most out of your insights

Get in touch